Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (20)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A)

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 272, Núm. 7, pp. 1229-1239

  2. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

    The Lancet Neurology, Vol. 21, Núm. 10, pp. 899-910

  3. Development and validation of a questionnaire for assessing patients´ perceptions of interprofessional integration in health care

    Journal of Interprofessional Care, Vol. 36, Núm. 4, pp. 538-544

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e22

  2. The association of telomere length with substance use disorders: a systematic review and meta-analysis of observational studies

    Addiction, Vol. 116, Núm. 8, pp. 1954-1972

2019

  1. Pattern of use of clozapine in Spain. Variability and under-prescription

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 151-162

2018

  1. Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study

    Schizophrenia Research, Vol. 195, pp. 334-342

2017

  1. Functional EEG network analysis in schizophrenia: Evidence of larger segregation and deficit of modulation

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 76, pp. 116-123

2016

  1. Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 8, pp. 743-753

  2. Identification of two clusters within schizophrenia with different structural, functional and clinical characteristics

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 64, pp. 79-86

2014

  1. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia

    Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 223-229

2013

  1. Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice

    Psychoneuroendocrinology, Vol. 38, Núm. 11, pp. 2462-2475

  2. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year

    Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161

2012

  1. Low frequency oscillations of response time explain parent ratings of inattention and hyperactivity/impulsivity

    European Child and Adolescent Psychiatry, Vol. 21, Núm. 2, pp. 101-109

2011

  1. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients

    NeuroImage, Vol. 56, Núm. 1, pp. 45-51

2008

  1. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia

    International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149